Advertisement
Quoin Pharma Says FDA Clears Recruitment Of Teen Subjects For Two Ongoing Clinical Trials For QRX003
(RTTNews) - Quoin Pharmaceuticals Ltd. (QNRX) announced Monday that the U.S. Food and Drug Administration (FDA) has cleared the recruitment of teen subjects aged 14 years and older into its two ongoing clinical trials for QRX003, which is being developed as a potential treatment for Netherton Syndrome (NS).
Both trials are being conducted under Quoin's open Investigational New Drug Application (IND) for QRX003. The clearance includes teen patients in both the company's open label and placebo controlled studies.
This important development represents the first ever inclusion of non-adult subjects in Netherton Syndrome clinical studies conducted under an open Investigational New Drug Application.
read more
FTSE 100 Down 0.4% In Cautious Trade
After a slightly positive start, U.K. stocks turned weak Thursday morning with investors treading cautiously amid a lack of triggers. Shares of financials and utilities companies are struggling a bit.
RTTNews
|
58 minutos atrás
CAC Up Slightly; Pernod Ricard Rises On Earnings
The French market is up slightly a little past noon on Thursday, supported by data showing an increase in new car registrations in Europe, and stronger-than-expected results and forecast from AI chip major Nvidia.
RTTNews
|
1h 16min atrás
DAX Retreats After Firm Start, Down Marginally
After opening on a strong note thanks to easing AI slowdown fears after Nvidia's impressive results, the German market retreated and slipped into negative territory on Thursday. Despite paring some early gains, auto stocks remain fairly well up in positive territory.
RTTNews
|
1h 40min atrás
Swiss Franc Rises Against Majors
The Swiss franc strengthened against other major currencies in the European session on Thursday.
RTTNews
|
1h 55min atrás
Sensex, Nifty Retreat On US Tariff Worries
Indian shares fell sharply on Thursday as traders waited to see how New Delhi responds to pressure from Washington to stop buying Russian oil after the 50 percent tariffs levied by the U.S. on Indian goods came into effect on Wednesday.
RTTNews
|
2h 1min atrás
Bank Of Korea Stands Pat On Rates, Lifts 2025 Growth Outlook
The Bank of Korea left its interest rate unchanged on Thursday as economic growth improved moderately despite high uncertainty surrounding the outlook. The Monetary Policy Board decided to hold the Base Rate at 2.50 percent. The central bank had previously lowered the benchmark rate by a quarter-point each in May and February.
RTTNews
|
2h 7min atrás
European Shares Mostly Higher As Nvidia Outlook Lifts Sentiment
European stocks were mostly higher on Thursday as Nvidia's positive results helped ease AI slowdown fears. U.K. markets underperformed as banks and utilities declined.
RTTNews
|
3h 19min atrás
Asian Shares Rise As Nvidia Beats Expectations
Asian stocks ended mostly higher on Thursday as Nvidia's strong results quelled worries over weakening AI demand.
RTTNews
|
3h 44min atrás
